In an event marking the start of the 16th Kerala Legislative Assembly, newly elected legislators swore their oaths on May 21. The oath-taki...

Uttar Pradesh Chief Minister Yogi Adityanath has asserted his authority following a recent cabinet expansion. The portfolio allocations dem...

Uttar Pradesh government has expanded its cabinet. New ministers and promoted leaders have been given important portfolios. This move stren...

Roche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...

C Joseph Vijay was sworn in as the new Chief Minister of Tamil Nadu. He and his cabinet ministers took their oaths as Members of the Tamil ...

The meeting was attended by Chief Secretary M Saikumar, Additional Chief Secretary to the Home, Prohibition and Excise Department, K Maniva...

Tamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...

A Trump administration immigration crackdown in Minnesota significantly disrupted federal investigations into serious crimes, leading to a ...

During a drug investigation in Florence, Alabama, a man not involved in the case was bitten by a police dog after resisting arrest. The man...

Ryan Wedding, a former Canadian Olympic snowboarder who is now on the top 10 Most Wanted list, faces new charges against him. Authorities b...

DCGI has ordered inspection of the two manufacturing facilities of Ranbaxy Laboratories that were banned from exporting medicines to the US.

India's drug regulator is working on a policy on how to respond to safety alerts by foreign regulator on medicines manufactured by Indian co

I stand by every pill that the company markets across the world, days after the company pleaded guilty on drug safety charges in the US for...

Former chief justice of Delhi High Court Rajinder Sachar has demanded that Indian authorities take steps to stop their use in the country.

The USFDA had banned Ranbaxy from selling 30 drugs after it found manufacturing deficiencies at facilities in India.

Ranbaxy pleaded guilty to felony charges related to drug safety & will pay $500 mn in fines under settlement agreement with US Department o...

The development follows the US Food and Drug Administration’s (USFDA) ban on Ranbaxy’s 30 generic drugs and seven APIs.